首页> 外国专利> Sustained-release pharmaceutical composition comprising mirabegron And method for manufacturing the same

Sustained-release pharmaceutical composition comprising mirabegron And method for manufacturing the same

机译:包含米拉贝隆的缓释药物组合物及其制备方法

摘要

The present invention is a sustained-release pharmaceutical composition comprising a mira begron and a method for preparing the same Regarding, more specifically, a drug moiety comprising a mirabegron or a pharmaceutically acceptable salt thereof and a cation exchange resin; And a sustained-release pharmaceutical composition formed on the outer surface of the drug part and including a sustained-release base coating, and a sustained-release pharmaceutical composition having a sustained-release base coating layer formed on the outer surface of the Mirabegron-resin composite. According to the present invention, since the sustained-release pharmaceutical composition comprising mirabegron is a sustained-release pharmaceutical composition in the form of particulates, when applied to elderly and pediatric patients with irritable bladder syndrome, it will provide excellent drug efficacy and ease of taking. Can be.
机译:本发明是包含米拉贝格隆的缓释药物组合物及其制备方法。更具体地讲,包含米拉贝隆或其药学上可接受的盐和阳离子交换树脂的药物部分;在药物部分的外表面上形成并包括缓释底涂层的缓释药物组合物,和在米拉格隆树脂的外表面上形成有缓释底涂层的缓释药物组合物综合。根据本发明,由于包含米拉贝隆的缓释药物组合物是呈颗粒形式的缓释药物组合物,当应用于患有肠易激综合症的老年和小儿患者时,它将提供优异的药物功效并且易于服用。可。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号